ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43421
0.00%
Bitcoin
95,705.09
-1.54%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sutro Biopharma Inc (STRO) Share Price

Sutro Biopharma Inc

Sutro Biopharma Inc (STRO)

NASDAQ
1.88
0.06
(3.30%)
Closed December 22 3:00PM
Delayed by 15 minutes
1.97
0.09
(4.79%)
After Hours: 6:36PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.97
Bid
1.86
Ask
5.43
Volume
2,345,221
1.7704 Day's Range 1.93
1.70 52 Week Range 6.13
Market Cap
162.444M
Previous Close
1.82
Open
1.79
Last Trade
20
@
1.95
Last Trade Time
Financial Volume
US$ 4,318,407
VWAP
1.8414
Average Volume (3m)
861,321
Shares Outstanding
82,458,725
Dividend Yield
-
PE Ratio
-1.44
Earnings Per Share (EPS)
-1.3
Revenue
153.73M
Net Profit
-106.79M

About Sutro Biopharma Inc

Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.sutrobio.com
Headquarters
South San Francisco, California, USA
Founded
-
Sutro Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker STRO. The last closing price for Sutro Biopharma was US$1.82. Over the last year, Sutro Biopharma shares have traded in a share price range of US$ 1.70 to US$ 6.13.

Sutro Biopharma currently has 82,458,725 shares outstanding. The market capitalization of Sutro Biopharma is US$150.07 million. Sutro Biopharma has a price to earnings ratio (PE ratio) of -1.44.

Ask ADVFN Intelligence (AI)

STRO Latest News

More News

Form 8-K - Current report

December 10 2024
Edgar (US Regulatory)

Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRαME-O1 Trial in Platinum Resistant Ovarian Cancer

- 32% objective response rate (ORR) in evaluable patients at the 5.2 mg/kg starting dose – the selected dose for randomized portion (Part 2) of ongoing registrational REFRαME-O1 trial - - These...

December 10 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

December 03 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 13 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 13 2024
Edgar (US Regulatory)

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights

- Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology - - Two new clinical trials, REFRαME-P1, a registration-enabling...

November 13 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 12 2024
Edgar (US Regulatory)

Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

November 04 2024
GlobeNewswire Inc.

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

November 01 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2-9.216589861752.172.231.716540991.98894511CS
4-0.52-20.88353413652.493.011.713783562.40113664CS
12-1.57-44.35028248593.544.61.78613212.89076697CS
26-1.06-34.98349834983.035.171.78120933.32659884CS
52-1.96-49.87277353693.936.131.78573633.85573309CS
156-13.54-87.298517085815.5116.111.76659585.02520116CS
260-8.63-81.415094339610.628.31.75231208.2180907CS

STRO - Frequently Asked Questions (FAQ)

What is the current Sutro Biopharma share price?
The current share price of Sutro Biopharma is US$ 1.97
How many Sutro Biopharma shares are in issue?
Sutro Biopharma has 82,458,725 shares in issue
What is the market cap of Sutro Biopharma?
The market capitalisation of Sutro Biopharma is USD 150.07M
What is the 1 year trading range for Sutro Biopharma share price?
Sutro Biopharma has traded in the range of US$ 1.70 to US$ 6.13 during the past year
What is the PE ratio of Sutro Biopharma?
The price to earnings ratio of Sutro Biopharma is -1.44
What is the cash to sales ratio of Sutro Biopharma?
The cash to sales ratio of Sutro Biopharma is 1
What is the reporting currency for Sutro Biopharma?
Sutro Biopharma reports financial results in USD
What is the latest annual turnover for Sutro Biopharma?
The latest annual turnover of Sutro Biopharma is USD 153.73M
What is the latest annual profit for Sutro Biopharma?
The latest annual profit of Sutro Biopharma is USD -106.79M
What is the registered address of Sutro Biopharma?
The registered address for Sutro Biopharma is 310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
What is the Sutro Biopharma website address?
The website address for Sutro Biopharma is www.sutrobio.com
Which industry sector does Sutro Biopharma operate in?
Sutro Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.5M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.63M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.84M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
8.58M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
5.96M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

Discussion

View Full Feed
SantaZar SantaZar 4 minutes ago
Done........for 3 diff EMails........lol

Z
Market Makers Exist Market Makers Exist 4 minutes ago
Company tweet stating all of 2025 will be a catalyst.
ILST
PonkenPlonken PonkenPlonken 4 minutes ago
any opinions at 42?
VKTX
Jack_Bolander Jack_Bolander 4 minutes ago
Banger - I really hope PLUG buys Hyzon. Just like the Drone Business.

With PLUG's management expertise and acumen Hyzon is sure to succeed.
HYZN
johnydollar johnydollar 5 minutes ago
Who knows maybe they are celebrating the trips....

But that is not enough.........

They want more.......

Like maybe kramers would come back and save them.........

Or the company would fold and go belly up.......

Or Revocation
DBMM
3331 3331 5 minutes ago
Your post/lies publicly discredit a veteran run organization (and veterans), and was spammed on numerous widely read boards.
BIEL
BBANBOB BBANBOB 5 minutes ago
Serafino

MERRY CHRISTMAS and HAPPY NEW YEAR TO YOU AS WELLLLLLLLLLLLLLLLLL
COOP
PonkenPlonken PonkenPlonken 5 minutes ago
https://www.ourcrowd.com/startup-news/alpha-tau-100-complete-response-rate-in-skin-cancer-trial?
might become SOC in inoperable tumors - super tech - revolutionize radio
DRTS
BakedLangostino BakedLangostino 5 minutes ago
Can you name a single pre-revenue competitor with fewer than 50 employees that is in a better financial position than Anavex right now?
AVXL
jeunke22 jeunke22 6 minutes ago
X, thank you for your detailed overview of Lightwave achievements over the last 4 years. This just shows everyone that the company is meticulous and steadily moving forward in building its business.
Lightwave has a breakthrough technology and some of the finest and most talented people work
LWLG
SantaZar SantaZar 6 minutes ago
We live in a state of perpetual dissociation from the almost unbearable wonder of being alive.

Wonder is always an edge state, its edge so sharp it threatens to rupture the mundane and sever us from what we mistake for reality — the TV, the townhouse, the trauma narrative.
Konaploinks Konaploinks 7 minutes ago
G.
API IONQ
SantaZar SantaZar 7 minutes ago
We live in a state of perpetual dissociation from the almost unbearable wonder of being alive.

Wonder is always an edge state, its edge so sharp it threatens to rupture the mundane and sever us from what we mistake for reality — the TV, the townhouse, the trauma narrative.
Konaploinks Konaploinks 7 minutes ago
Homework. COLLEGE PARK, MD — FEBRUARY 15, 2024

IonQ Opens Doors to First Dedicated Quantum Computing Manufacturing Facility in the U.S..

Senator Maria Cantwell (D-Wash.) cut the ribbon on new facility alongside IonQ leaders
Facility will manufacture quantum comp
API IONQ
81vette 81vette 7 minutes ago
35k watchers now!! That’s huge,if big name pumpers start promoting,could really fly
ABAT
gitreal gitreal 8 minutes ago
Why? Why is he scared?

Because he has been the main promoter for at least three OTC dilution scams, over a dozen years. Because disclosure of his real identity will unravel the whole scam, and possibly result in multiple scumbags facing the legal system. "Discovery" would be quite i
AABB
SantaZar SantaZar 8 minutes ago
We live in a state of perpetual dissociation from the almost unbearable wonder of being alive.

Wonder is always an edge state, its edge so sharp it threatens to rupture the mundane and sever us from what we mistake for reality — the TV, the townhouse, the trauma narrative.
nyt nyt 8 minutes ago
If they win the win the antitrust suit, will they take "monopoly money" for pymt?
VPLM
gfp927z gfp927z 9 minutes ago
>>> Arthur J. Gallagher & Co. (AJG), together with its subsidiaries, provides insurance and reinsurance brokerage, consulting, and third-party property/casualty claims settlement and administration services to entities and individuals worldwide. It operates in Brokerage and Risk Management segments.
AJG
SantaZar SantaZar 9 minutes ago
We live in a state of perpetual dissociation from the almost unbearable wonder of being alive. Wonder is always an edge state, its edge so sharp it threatens to rupture the mundane and sever us from what we mistake for reality — the TV, the townhouse, the trauma narrative. If we fell asleep each nig
crazy horse 0 crazy horse 0 9 minutes ago
Sean Spicer’s Lost Court Case Sets Huge Precedent for 47: 'Trump Can Go in and Fire Everyone'

Can President-elect Donald Trump shake up the federal government by firing whoever he wishes on day one of his new administration? Former Trump White House press secretary Sean Spicer says ye
badog badog 10 minutes ago
I have no other conclusions...the ones I post seem most accurate. The 14,000 post guy deals in facts....not clues and speculations and what if's and Christmas Suprises that don't come. You admit that Krom is posting unverified, overly positive narratives so maybe if you didn't worry so much abo
ERHE
Konaploinks Konaploinks 11 minutes ago
Homework: It’s fun making money with knowledge!. .
Yes, IonQ is a leading force in quantum computing manufacturing in Bothell, Washington. In February 2024, they opened the United States’ first dedicated quantum computing manufacturing facility in Bothell, marking a significant milestone in
IONQ
Snake River Dog Snake River Dog 11 minutes ago
(IMTL) (BYOC) (NAFS) Expecting Major News!! On These!! at some Point!! (NAFS .0001) Really under the Radar!! Some .0001s still Available. (Stocks To Watch!!)
BYOC IMTL NAFS
PonkenPlonken PonkenPlonken 11 minutes ago
has a lot of critical readouts coming soon - see below
neglected and forgotten...
DRTS

Your Recent History

NASDAQ
STRO
Sutro Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads